Nicardipine Hydrochloride Injection
Product Images NDC 0143-9542
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 0143-9542). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label Nicardipine Premier From 08-2015 (Nicardipine Hydrochloride Injection Premierprorx 2)
Nicardipine Hydrochloride Injection is a medication available in 25 mg per 10 mL (2.5 mg/mL) doses. It should be diluted before use and any unused portion should be discarded. This medication is intended for intravenous use. Each 10 mL of the injection contains 25 mg of Nicardipine HCI, 3.05 mg of benzolc acid, USP, and 75 mg of sodium chloride, USP, in Water or Injection, USP. Sodium hydronde may have been added. This medication should be protected from light, stored at 20°C to 25°C (68" to 77°F), and retained in its carton. The dosage would be determined by the physician or health care provider and should be consulted before use. Lot number and expiration date information are provided.*
Nicardipine Hydrochloride Injection Premierprorx 3
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.